
‘Cult' of tourniquets causing thousands of unnecessary amputations and deaths in Ukraine, say surgeons
Captain Rom A Stevens, a retired senior US medical navy officer who has served in Iraq, Afghanistan, and East Africa, estimates that of the roughly 100,000 amputations performed on Ukrainian soldiers since Russia's full-scale invasion in 2022, as many as 75,000 were caused by improper use of tourniquets.
'I've seen tourniquets that have been left on for days, often for injuries that could have been stopped by other methods. Then [the patient] has to have their limb amputated because the tissue has died,' Captain Stevens told The Telegraph.
Tourniquets are strong bands used to stop catastrophic bleeding by cutting off blood flow, and are standard issue for most modern armies.
But if left on over two hours, they can cause tissue death, meaning the arm or leg which has the tourniquet on is no longer viable and requires amputation.
The device became standard-issue in the 2000s wars in Iraq and Afghanistan, where rapid air evacuation to military surgical teams was possible in under 60 minutes. If the tourniquet was unnecessary it was removed, and no harm was done.
But in Ukraine, where the skies are infested with drones and no med-evac helicopters fly, injured soldiers are evacuated by land, often far exceeding the safe time window for tourniquet use.
This critical delay has caused tens of thousands of amputations, say experts, many of which were unnecessary because the injuries didn't require a tourniquet in the first place.
It has also led to a sharp rise in young Ukrainians needing dialysis, said Captain Stevens who has served as a medical volunteer in hospitals in Zaporizhzhiya, Dnipro, and L'viv since the invasion in 2022.
This is because when a tourniquet is removed after being kept on too long, toxins from dead tissue flood the bloodstream, overwhelming the kidneys.
Captain Stevens helped draft the US military guidelines for tourniquet use and now wishes greater emphasis had been placed on assessing when they were needed to stop bleeding.
He fears that their successful use in wars where rapid evacuation was possible has led to a 'cult-like' dependence on a tool that should be used much more sparingly.
In Ukraine, it has left 'a generation of men traumatised by unnecessary amputations,' he said.
The US Tactical Combat Casualty Care (TCCC) handbook was created for trained military medics operating in war zones in the 1990s and heavily promotes the use of tourniquets in war, describing their use as 'the best method to control life-threatening bleeding'.
Widely adopted by NATO and Western armed forces in the early 2000s, the TCCC standards were quickly integrated into Ukrainian military and civilian medical training following the Russian invasion of Crimea in 2014.
Captain Stevens – though an author of the TCCC – says this was a error.
'If you have a perfect battlefield, then tourniquets work. But if you don't – if you have a situation like Ukraine today – you can end up with a tragedy. And that's what the Ukrainians have,' he said.
'There's now hundreds of thousands of tourniquets that have been distributed to military forces, civilians, fire departments, and police in Ukraine. It's become a cult, and because it saved lives in Iraq and Afghanistan, people think it's a good idea,' he added.
While most Western militaries embed specialist medics in every unit, Ukraine's armed forces – made up largely of conscripts and civilian volunteers – often rely on medics with only a few weeks or even days of training who are often unable to distinguish between injuries that do and don't require tourniquets.
'The Ukrainian infantry and artillery battalions are undermanned. They can't replace their medics when they get injured or killed,' Captain Stevens said.
A 2022 study by a Ukrainian military vascular surgeon, Dr Vladyslav Yatsun, found that only 24.6 per cent of war wounded patients arriving at hospital with tourniquets had injuries that justified their use to stop bleeding.
'In all other cases, the use of pressure bandages was more appropriate,' the study said.
They are also often being applied too high on damaged limbs, said Captain Stevens. 'They are often taught to place on the tourniquets well above the wounds, and the result is a very high amputation, making it difficult to later fit a prosthesis,' he said.
An updated version of the Ukrainian TCCC disseminated to the armed forces in January 2024 specifically reads: 'Place the tourniquet 'high and tight' on the wounded extremity.'
NATO has also raised concerns about tourniquets in Ukraine.
Last year, the agency dispatched a team of medical and military experts to investigate what it described as 'an unacceptable high complication rate from the use of tourniquets [...] resulting in amputations, renal failure and even death.'
The organisation added: 'The current situation with prolonged evacuation times requires a shift in attitude towards tourniquets,' although it has yet to formally publish its recommendations.
Experts stress that tourniquets continue to save many lives and should not be abandoned.
Instead, they say that in places like Ukraine where rapid evacuation is difficult they should only be used in the three circumstances in which they are absolutely necessary.
The first is when a limb has been completely severed. 'In that situation, you need a tourniquet, but you need to put it as low down as possible to try and save as much of the limb as you can,' said Captain Stevens.
The second is when the limb is so damaged that it cannot be saved – a decision that requires judgement and medical experience.
The third is when a person has uncontrolled arterial bleeding that cannot be stopped with direct pressure or any other method.
Captain Stevens said tourniquets are often applied by panicked soldiers, who lack the knowledge or confidence to try other methods first.
'When a [Ukrainian] soldier is injured in the field, they're usually taken care of by other soldiers in a panic,' he said. 'They see blood. They put on tourniquets because they have tourniquets. We gave them tourniquets.'
Dr Ostap Zubach, an orthopaedic surgeon who works at a major trauma hospital in L'viv, agrees that while tourniquets can be life-saving, they can also be deadly when used incorrectly.
'As a doctor, I believe that in the right hands, tourniquets are a brilliant thing. But in the wrong hands, they can be very dangerous,' he said.
A particular problem was that many soldiers did not know how to temporarily loosen a tourniquet periodically to extend the time of safe use.
'The strategy of tourniquets [in Ukraine] is just not working, especially when [the soldiers] don't know how to convert them,' said Dr Zubach. 'Many of our soldiers have no experience in the military or medicine.'
Major General Anatoliy Petrovych Kazmirchuk, Commander of the Medical Forces of the Ukrainian Army, introduced tourniquet 'conversion' into the basic military training programme last year following reports of excessive amputations and limb loss at the front.
But both Captain Stevens and Dr Zubach are sceptical on what impact the new training is having.
'The problem is that under fire, people are afraid to take the tourniquets down. They're in a rush to get that patient to a hospital surgeon and don't stop to convert them,' said Captain Stevens.
A growing group of medics both in and outside of Ukraine are now putting pressure on the ministry of defence to move away from the TCCC handbook and develop their own set of medical guidelines for use in the Ukrainian context, factoring in long evacuation times.
'Guidelines are only guidelines. They require common sense to apply, they require professional judgement. In Ukraine, they don't have a system for developing guidelines. Often they just take Western, US, British, NATO guidelines, and translate them, word for word into Ukrainian,' said Captain Stevens.
'But there's a lot of resistance to changing it. The Ukrainians are taking their cue from the Americans, but our protocols were not designed for this situation,' he added.
'If you go back to World War Two and you read what the American theatre surgeons had to say about tourniquets, they said they were dangerous because they were often placed on wounds that did not require them, and then not taken off before it was too late,' he said.
'You didn't have a rapid evacuation there either. You're evacuating by land, over bumpy roads, in the middle of the night under fire, just like what the Ukrainians are doing now.'
Both Dr Zubach and Captain Stevens say more emphasis needs to be put on basic casualty care, like cutting off clothes to examine the wound to see the source of bleeding, use of pressure bandages, and alginates – jelly-like dressings that can absorb heavy bleeding and pack into wounds without the long-term risks associated with a tourniquet.
Both agree that tourniquets should be used only as a last resort, when all else has failed. 'Soldiers and medics need to understand that when a tourniquet is placed on the Ukrainian battlefield, it usually means an amputated limb,' says Stevens.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Independent
an hour ago
- The Independent
‘Contradiction' in figures makes health experts question NHS data
Health analysts have said they have spotted a 'contradiction' in NHS data as they called for more transparency in the way waiting list figures are reported. Experts suggest that more patients are being referred for treatment than leaving the waiting list, despite the overall waiting list coming down. Analysis found that in May, for every 100 referrals for pre-planned care, only 86 patient 'pathways' were complete – a scenario that would expect to see the waiting list getting bigger. But the official figures for May, published last month, show that the waiting list for routine hospital treatment in England had dropped to its lowest level for more than two years. 'There appears to be a contradiction in the data,' analysts from the Nuffield Trust think tank said. Writing a piece for part of the Quality Watch programme, the experts claim that an increase in NHS activity alone has not been enough to cause the reduction in the waiting list. Their new report examines so-called 'unreported removals', which occur when someone is taken off the waiting list for a reason other than that person having received their treatment that month. The report says that over the last two financial years there has been an average of 244,500 unreported removals a month. Though the waiting list has started to go down, unreported removals have gone up, they add. Officials from the Department and Health and Social Care insist that over the last 12 months, the number and percentage of unreported removals are lower than 2019. The new report points out that some of these unreported removals will represent patients that did get treatment but it was not recorded properly at the time. Another issue could be problems with NHS software and data management processes. The authors of the review wrote: 'Improving the data quality of waiting lists is important to ensure that people who should not be on the list, like people who have been treated privately or left the country, are no longer counted among those waiting to be seen. 'However, accusations of gaming the validation process, by removing referrals from the waiting list inappropriately without treatment, are likely to persist in the absence of transparency about what actions the unreported removals materially represent. 'The NHS is delivering more planned care, but still not enough to keep up with demand. 'The planned care that is reported is not enough to explain the reduction in the elective waiting list, and the publicly available data provides little more insight.' Officials estimate that 85% of the reduction in the waiting list is because of increased NHS 'activity' and suggest that 15% is because of unreported removals. According to the latest NHS figures, an estimated 7.36 million treatments were waiting to be carried out at the end of May, relating to just under 6.23 million patients, down from 7.39 million treatments and just over 6.23 million patients at the end of April. These are the lowest totals since March 2023 for treatments and April 2023 for patients. The list hit a record high in September 2023, with 7.77 million treatments and 6.50 million patients. The size of the list had been on an upward trend for much of the last 10 years, passing three million treatments in 2014, four million in 2017, five million in 2021 and seven million in 2022. In February 2020, the last full month before the start of the Covid-19 pandemic, the list stood at 4.57 million treatments. The authors of the latest review add: 'The information available in the public domain is insufficient for independent scrutiny of the elective waiting list, and consequently for holding government to account. 'Removals from the waiting list should be described in publicly available data in a meaningful way; the current process is unduly obscure. 'Until more transparent reporting is provided, accountability around unreported removals remains impossible and the planned care waiting list will continue to be a misleading indicator of how the NHS is dealing with demand.' It comes as the NHS in England is to reveal its latest waiting list figures on Thursday. Commenting on the analysis, an NHS England spokesperson said: 'NHS staff have made significant progress in reducing waiting lists in the last year – down by more than 260,000 since June 2024 – and this is driven by the fact that 2,300 more patients are receiving treatment every day compared to last year.' 'While the validation process has a small impact on the overall waiting list – as is made crystal clear in our published monthly waiting list data – it's right we regularly clinically review those waiting so hospitals can prioritise patients more accurately and deploy their resources efficiently.' A Department of Health and Social Care spokesperson added: 'Our drive to clear the huge waiting list backlog we inherited includes making sure all patients are getting the right treatment as quickly as possible. 'That's why we are supporting GPs to seek specialist advice before making referrals, and screening existing waiting lists to check that all patients need to be on there – freeing up capacity to get more people seen more quickly. 'This is one element of our wider work to cut waiting times for patients and improve productivity through our Plan for Change, through which we have already delivered over four million extra appointments and cut the waiting list by 260,000.'


The Sun
3 hours ago
- The Sun
How booming ‘fat jab' black market is STILL rife after celeb stylist sells meds to Sun reporter for £280 via Instagram
WEIGHT loss drugs are still being brazenly flogged on the black market by a celebrity hairdresser who gave The Sun a Mounjaro jab with NO consultation, Sun Club can reveal. The news has led Mounjaro manufacturer Lilly to beg those taking weight loss drugs to only buy from a licensed healthcare professional and warn that "dangerous" black-market products are often made in "unsanitary conditions". 9 9 9 As part of a Sun probe, we obtained self-injectable Mounjaro, dubbed the King Kong of fat jabs, for £280 after responding to an Instagram post by celeb stylist Ozzy Tudo, who is known for working with Katie Price and telly personality Jessica Alves. Our reporter was sold potentially deadly prescription weight loss drugs by Tudo, despite having a normal BMI and telling him she wanted to shed at least one stone in just TWO WEEKS before going "on holiday". The investigation exposed the ease of obtaining the fashionable diet drugs on the booming black market and, despite being confronted about the illegal sale on hidden cameras, Tudo has now started openly selling them again. Less than 24 hours ago, he posted an image of a slim model in white underwear with bottles of Mounjaro underneath and wrote the caption: "Available at great price #mounjaro." He also then posted an image of a Mounjaro injection pen to his 72k followers with the words: "#mounjaro. Very effective." When we asked Tudo about him continuing to sell Mounjaro over Instagram, he said: 'Why don't u go after the pharmacies which sells hundreds or thousands of pens without prescription [sic]? "It's no me do does wrong , it's these big companies, pharmacies and suppliers who sells to everyone who pays pharmacies accept fake prescriptions or without prescription [sic]." Asked to provide evidence that he was a qualified prescriber, Tudo refused to respond. Weight loss drugs can only be lawfully supplied when prescribed for someone by an appropriate practitioner – such as a doctor, a nurse or a pharmacist-independent prescriber - after a detailed health assessment. Mounjaro - which has been linked to 33 deaths in the UK - is approved for adults who are classed as "obese", so with a BMI of 30 or more, or those with a BMI of 27 or more who also have weight-related health conditions. I went on fat jabs but the hair loss was unbelievable so I quit - I'd rather be chubby with hair than skinny and bald However, earlier this year our reporter - who has a BMI of 21 - contacted Tudo through a mobile number on his Instagram account, which he uses to advertise Mounjaro and Ozempic. She told him she weighed nine-and-a-half stones, a size small dress size, and wanted to shed at least one stone before going on a holiday. She was not asked her height or her BMI. She was also not asked for her name or address. Tudo, 47, advised that a dose of 5mg 'is enough' and said to travel to his studio near King's Cross Station in London, where he would supply the drug. Once at the address, a woman, who did not speak English, led us up a staircase and handed over a brown paper bag containing the pen - which holds four injections of the drug, to be taken once a week for a month. With no consultation or explanation of how the prescription drug works, our reporter messaged Tudo saying: 'I don't know how to take it.' He replied: "Send u a video. It's so easy." The hairdresser then sent a YouTube tutorial video on how to self-inject. Asked if it would have any side effects, he replied: "It depends on each person, usually no." When we later confronted Tudo about the illegal sale, which was filmed using concealed cameras, he said: 'I don't even have Mounjaro here.' Pressed on how he prescribed the drug, which has been linked to 'deaths' without the necessary qualifications or even asking our undercover reporter for a name, he said: 'Deaths? No. Just a few overdoses.' Harley Street doctor Sophie Shotter, who has been practising for 16 years, said it was "terrifying' and a "risk to public health" that The Sun had obtained the drug without any medical consultation. Everything you need to know about fat jabs Weight loss jabs are a hot media topic at the moment, with hundreds of success stories from people who shed the pounds. In March 2023, the NHS announced it would make Wegovy, a drug made by Danish firm Novo Nordisk, available on prescription to thousands of obese Brits. It contains the drug semaglutide, which is said to have helped reality star Kim Kardashian and Twitter boss Elon Musk lose weight. Wegovy, which helped a third of people reduce their weight by 20 per cent in trials, is now available from pharmacies like Boots. How do they work? The jabs work by suppressing your appetite, making you eat less and therefore lose weight. To do this, semaglutide mimics the role of a natural hormone, called GLP-1. GLP-1 is part of the signalling pathway that tells your body you have eaten, and prepares it to use the energy that comes from your food. London GP and founder of Dr Zoe Watson, said: 'Your body naturally produces an appetite regulating hormone called glucagon-like peptide-1. 'These jabs work by regulating your appetite, which can lead to eating fewer calories and losing weight.' Aren't they diabetes drugs? Semaglutide, the active drug in Wegovy, was originally sold under the name Ozempic specifically for diabetes patients. But people started noticing it helped suppress their appetites, stopping them eating as much and helping them shed the pounds. Novo Nordisk then developed Wegovy, which contains the same chemical but at higher doses specifically to aid weight loss. Wegovy is not prescribed for diabetes patients. Can I get them? Wegovy is offered on prescription to obese adults given specialist weight loss treatment. The NHS currently also offers a similar drug called Saxenda, or liraglutide. Both are only available throught specialist weight management services, which means you have to be referred to clinics led by experts. GPs can't prescribe them on their own, Dr Watson said. The jabs have to be taken as part of an overall programme to help with lifestyle changes and psychological support to get the best effect from the medication prescribed. Are there any risks? Like all medicines, the jabs do not come without side effects. Around half of people taking the drug experience gut issues, including sickness, bloating, acid reflux, constipation and diarrhoea. Dr Sarah Jarvis, GP and clinical consultant at said: 'One of the more uncommon side effects is severe acute pancreatitis, which is extremely painful and happens to one in 500 people.' Other uncommon side effects include altered taste, kidney problems, allergic reactions, gallbladder problems and hypoglycemia. What other options are there? Mounjaro (brand name for tirzepatide) also came onto the market in early 2024. Like Wegovy, tirzepatide stems from a drug originally designed to treat diabetes. The weekly injection helped overweight people drop more than two stone in 18 months. It is available with to order with a prescription online from pharmacies including Superdrug and LloydsPharmacy Online Doctor. It works in a similar way to Wegovy and Saxenda, but is more effective. Dr Mitra Dutt from LloydsPharmacy says: 'Based on clinical trials, 96 per cent of people were able to lose more than five per cent of their body fat using Mounjaro. In similar trials, 84 per cent of people lost more than five per cent of their body weight on Wegovy, and 60 per cent on Saxenda. 'Mounjaro works by activating two hormonal receptors (GIP and GLP-1), which enhance insulin production, improve insulin sensitivity, and work to decrease food intake." After examining the pen at her Harley Street practice, Dr Shotter said: "This is a controlled, prescription-only drug. "This is a UK-approved pen, so this has not been smuggled into the country. "It is a huge concern, because, how has it appeared on the black market in the first place? "If you [our reporter] came into my surgery asking to go on a weight loss drug, immediately the answer would be, 'No.' "If you lost one to two stones, you could drop into a low BMI category. "This is not what the drug is intended for and it is, quite frankly, terrifying that you've been able to buy it. And not just that, it is the fact, you've been placed on a higher dose. "If a patient came to me who did qualify because of their weight, then I would have a thorough consultation with them. 'I would possibly run blood tests to ensure it is as safe as possible and to make sure there are no underlying liver or pancreatic problems. "This man has not even asked you your name, so how is the drug being prescribed? It is impossible that this is legitimate. "It is a genuine risk to public health and especially dangerous to those with eating disorders. 'These drugs carry risks to your health and your mental health, especially to those who suffer from eating disorders.' 9 9 9 9 The rise in the 'dangerous' black market availability of weight loss injections is being increasingly seen by eating disorder charities in the UK. After being informed about The Sun's investigation, Tom Quinn, Beat's Director of External Affairs said: "We're incredibly concerned that it's so easy to access weight loss injections on the black market. "Medications which cause weight loss can be very attractive to people with eating disorders, and can contribute to these dangerous mental illnesses getting worse. "They pose severe health risks, especially if they are easily accessible without prescriptions. "Weight loss injections are very serious medications with severe side effects such as vomiting and nausea, which can contribute to an eating disorder developing, or make it worse. "We also have concerns about what happens after somebody stops taking these drugs. If somebody gains weight after their prescription finishes, this may trigger feelings of guilt and shame, which could increase the chances of an eating disorder developing. "More action needs to be taken to prevent these drugs being so easily accessible. 'And it's vital that there is more education so that people are aware of how dangerous it is to abuse medication in order to lose weight. "For those with binge eating disorder, losing weight won't help a person recover from an eating disorder. 'While it may bring their BMI down in isolation, it will do nothing to address the root cause or symptoms of the eating disorder – and could make things worse. "Doctors and pharmacies must make the general public aware of these dangers, and ensure that prescriptions are only possible after stringent health checks." BLACK MARKET Medicines bought on the black market that have not been through rigorous safety testing bring additional risks. The market leaders Mounjaro, which contains tirzepatide, and Ozempic, which contains semaglutide, are administered via injection of pre-filled pens. They work by mimicking the hormone glucagon-like peptide-1, which is released after eating, and suppresses a patient's appetite. The National Institute of Health and Care Excellence (Nice) recommends semaglutide for adults who have at least one weight-related comorbidity and a body mass index (BMI) score of at least 35, or a BMI of at least 30 and meet criteria for referral to a specialist weight management service. A Lily spokesperson said: "Patients should only use Mounjaro (tirzepatide) when prescribed by a licensed healthcare professional and prescriptions should be fulfilled and supplied only by registered pharmacies and providers. Any tirzepatide offered without a prescription or for purchase on social media or black market is unlawful. These products are either fake or being 'resold' by an individual who obtained them through illicit means. Both practices put patients at risk. "Counterfeit, fake, and other unsafe products that are sold in a manner that falsely represents their authenticity, origin, or effectiveness are dangerous. These black-market products are often made in unsanitary conditions, which is especially dangerous for sterile injectables, like tirzepatide. "They may contain the wrong ingredients, contain too much, too little, or no active ingredient at all, or contain other harmful ingredients. No one should ever risk putting them into their bodies. "Lilly has taken steps to help address the risks posed by the proliferation of counterfeit, fake, and unsafe products across the world, including working with regulators and law enforcement, and identifying and removing fraudulent or unsafe content online and on social media — and we will continue to pursue all available avenues to combat fake and black-market medicines. "But our efforts alone are not enough. We applaud the MHRA's warnings on the risks of unsafe fake weight loss pens and the risks of buying medicines online without a prescription, and we welcome their continued partnership in the fight against counterfeit and illegal medicines. "We call upon regulators and law enforcement across the globe to take action against those who threaten the health and wellbeing of patients by selling fake or unsafe medicines." 9 9


The Independent
4 hours ago
- The Independent
Struggling to sleep? Your gut bacteria could be to blame
Your gut health can impact everything from your mood to your immune system, but it could also be the cause of your poor sleep, a study has found. Specific types of gut bacteria have been linked to insomnia risk by researchers, while insomnia itself has also been linked to an abundance of certain 'bugs' in the gut. Insomnia, which means a person has difficulty falling and staying asleep, affects about a third of adults in the UK. It can be caused by anxiety, noise, alcohol, caffeine or shift work, according to the NHS. Several studies have explored the effects of the gut microbiome on various sleep characteristics, but it's not yet clear how different groups of gut bacteria might affect the risk of insomnia. The study, published in the journal General Psychiatry, used data on 386,533 people with insomnia from a previously study, gut microbiome data for 18,340 people from the MiBioGen alliance and for 8,208 people from the Dutch Microbiome Project with 71 groups of bacteria in common. Their analysis revealed associations between specific gut microbes and insomnia. Overall, a total of 14 groups of bacteria were positively associated with insomnia and eight groups showed a negative association. Insomnia itself was associated with a reduction of between 43 per cent and 79 per cent in the abundance of seven groups of bacteria and a 65 per cent to a more than fourfold increase in the abundance of 12 other groups. Researchers found the Odoribacter class of bacteria, in particular, was significantly associated with the risk of insomnia. This type of bacteria plays a role in producing short-chain fatty acids like butyrate, which in the right levels can help maintain a healthy gut. However, there are some limitations to the study. All the study participants were of European descent, so the results may not be more widely applicable as the make-up of the microbiome varies among different ethnicities and geographies, researchers point out. Diet and lifestyle – which affect the microbiome – were also not accounted for. Although bacteria are linked to insomnia, those same bacteria may be shaped by a person's eating habits, stress levels, and environment. 'Overall, the intertwined effects of insomnia on gut microbiota, and vice versa, represent a complex bidirectional relationship involving immune regulation, inflammatory response, release of neurotransmitters, and other molecular and cellular pathways,' study authors said. The authors conclude: 'Our study offers preliminary evidence supporting a causal effect between insomnia and gut microbiota, providing valuable insights for the future development of microbiome-inspired treatment plans for insomnia.' These treatment plans might include the use of probiotics, prebiotics, or faecal microbiota transplantation, they suggest.